These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 23286282

  • 1. Pathology of central nervous system posttransplant lymphoproliferative disorders: lessons from pediatric autopsies.
    Gheorghe G, Radu O, Milanovich S, Hamilton RL, Jaffe R, Southern JF, Ozolek JA.
    Pediatr Dev Pathol; 2013; 16(2):67-73. PubMed ID: 23286282
    [Abstract] [Full Text] [Related]

  • 2. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.
    J Clin Oncol; 2007 Nov 01; 25(31):4902-8. PubMed ID: 17971586
    [Abstract] [Full Text] [Related]

  • 3. Posttransplant lymphoproliferative disorder of the central nervous system.
    Kempf C, Tinguely M, Rushing EJ.
    Pathobiology; 2013 Nov 01; 80(6):310-8. PubMed ID: 24013167
    [Abstract] [Full Text] [Related]

  • 4. Autopsy pathology of pediatric posttransplant lymphoproliferative disorder.
    Collins MH, Montone KT, Leahey AM, Hodinka RL, Salhany KE, Belchis DA, Tomaszewski JE.
    Pediatrics; 2001 Jun 01; 107(6):E89. PubMed ID: 11389287
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
    Ginat DT, Purakal A, Pytel P.
    J Neurooncol; 2015 Nov 01; 125(2):297-305. PubMed ID: 26341369
    [Abstract] [Full Text] [Related]

  • 6. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
    Arita H, Izumoto S, Kinoshita M, Okita Y, Hashimoto N, Fujita T, Ichimaru N, Takahara S, Yoshimine T.
    Neurol Med Chir (Tokyo); 2010 Nov 01; 50(12):1079-83. PubMed ID: 21206182
    [Abstract] [Full Text] [Related]

  • 7. Posttransplant lymphoproliferative disorder: a pictorial review.
    Burney K, Bradley M, Buckley A, Lyburn I, Rye A, Hopkins R.
    Australas Radiol; 2006 Oct 01; 50(5):412-8. PubMed ID: 16981935
    [Abstract] [Full Text] [Related]

  • 8. Abdominal involvement in pediatric heart and lung transplant recipients with posttransplant lymphoproliferative disease increases the risk of mortality.
    Tai CC, Curtis JL, Szmuszkovicz JR, Horn MV, Ford HR, Woo MS, Wang KS.
    J Pediatr Surg; 2008 Dec 01; 43(12):2174-7. PubMed ID: 19040929
    [Abstract] [Full Text] [Related]

  • 9. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H, Taheri S.
    Ann Transplant; 2011 Dec 01; 16(1):109-16. PubMed ID: 21436784
    [Abstract] [Full Text] [Related]

  • 10. Classification of the posttransplant lymphoproliferative disorders: from the past to the present.
    Swerdlow SH.
    Semin Diagn Pathol; 1997 Feb 01; 14(1):2-7. PubMed ID: 9044504
    [Abstract] [Full Text] [Related]

  • 11. Posttransplant lymphoproliferative disorder in pediatric patients: Survival rates according to primary sites of occurrence and a proposed clinical categorization.
    L'Huillier AG, Dipchand AI, Ng VL, Hebert D, Avitzur Y, Solomon M, Ngan BY, Stephens D, Punnett AS, Barton M, Allen UD.
    Am J Transplant; 2019 Oct 01; 19(10):2764-2774. PubMed ID: 30884098
    [Abstract] [Full Text] [Related]

  • 12. Posttransplant lymphoproliferative disorder: significance of central nervous system involvement.
    Buell JF, Gross TG, Hanaway MJ, Trofe J, Roy-Chaudhury P, First MR, Woodle ES.
    Transplant Proc; 2005 Mar 01; 37(2):954-5. PubMed ID: 15848587
    [Abstract] [Full Text] [Related]

  • 13. Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
    Twombley K, Pokala H, Ardura MI, Harker-Murray P, Johnson-Welch SF, Weinberg A, Seikaly M.
    Pediatr Transplant; 2012 Sep 01; 16(6):E201-9. PubMed ID: 22646132
    [Abstract] [Full Text] [Related]

  • 14. Radiologic Differentiation of Primary CNS Posttransplant Lymphoproliferative Disorder From Brain Metastasis.
    White ML, Zhang Y, Cramer J, Yu F, Bierman PJ, Greiner TC.
    AJR Am J Roentgenol; 2020 Jul 01; 215(1):184-191. PubMed ID: 32348186
    [Abstract] [Full Text] [Related]

  • 15. Central nervous system lymphoproliferative disorder in pediatric kidney transplant recipients.
    Traum AZ, Rodig NM, Pilichowska ME, Somers MJ.
    Pediatr Transplant; 2006 Jun 01; 10(4):505-12. PubMed ID: 16712612
    [Abstract] [Full Text] [Related]

  • 16. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Cavaliere R, Petroni G, Lopes MB, Schiff D, International Primary Central Nervous System Lymphoma Collaborative Group.
    Cancer; 2010 Feb 15; 116(4):863-70. PubMed ID: 20052713
    [Abstract] [Full Text] [Related]

  • 17. Primary central nervous system post-transplantation lymphoproliferative disorder.
    Dierickx D, Tousseyn T, Verhoef G.
    Cancer; 2010 Jul 15; 116(14):3521; author reply 3521-2. PubMed ID: 20564159
    [No Abstract] [Full Text] [Related]

  • 18. Primary CNS posttransplant lymphoproliferative disease (PTLD): an international report of 84 cases in the modern era.
    Evens AM, Choquet S, Kroll-Desrosiers AR, Jagadeesh D, Smith SM, Morschhauser F, Leblond V, Roy R, Barton B, Gordon LI, Gandhi MK, Dierickx D, Schiff D, Habermann TM, Trappe R.
    Am J Transplant; 2013 Jun 15; 13(6):1512-22. PubMed ID: 23721553
    [Abstract] [Full Text] [Related]

  • 19. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
    Krishnamurthy S, Hassan A, Frater JL, Paessler ME, Kreisel FH.
    Int J Surg Pathol; 2010 Aug 15; 18(4):278-85. PubMed ID: 19578050
    [Abstract] [Full Text] [Related]

  • 20. Sustained response to intrathecal rituximab in EBV associated Post-transplant lymphoproliferative disease confined to the central nervous system following haematopoietic stem cell transplant.
    Bonney DK, Htwe EE, Turner A, Kelsey A, Shabani A, Hughes S, Hughes I, Wynn RF.
    Pediatr Blood Cancer; 2012 Mar 15; 58(3):459-61. PubMed ID: 21584931
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.